These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34062463)

  • 21. A multiplex real-time PCR assay for the detection and differentiation of five bovine pinkeye pathogens.
    Zheng W; Porter E; Noll L; Stoy C; Lu N; Wang Y; Liu X; Purvis T; Peddireddi L; Lubbers B; Hanzlicek G; Henningson J; Liu Z; Bai J
    J Microbiol Methods; 2019 May; 160():87-92. PubMed ID: 30930057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review and meta-analysis of the antibiotic treatment for infectious bovine keratoconjunctivitis: an update.
    Cullen JN; Yuan C; Totton S; Dzikamunhenga R; Coetzee JF; da Silva N; Wang C; O'Connor AM
    Anim Health Res Rev; 2016 Jun; 17(1):60-75. PubMed ID: 27427193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial efficacy of in vitro and ex vivo photodynamic therapy using porphyrins against Moraxella spp. isolated from bovine keratoconjunctivitis.
    Seeger MG; Machado CS; Iglesias BA; Vogel FSF; Cargnelutti JF
    World J Microbiol Biotechnol; 2022 May; 38(6):103. PubMed ID: 35501420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves.
    Arora AK; Killinger AH; Mansfield ME
    Am J Vet Res; 1976 Jul; 37(7):803-5. PubMed ID: 937804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moraxella spp. isolated from field outbreaks of infectious bovine keratoconjunctivitis: a retrospective study of case submissions from 2010 to 2013.
    Loy JD; Brodersen BW
    J Vet Diagn Invest; 2014 Nov; 26(6):761-8. PubMed ID: 25261461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimum inhibitory concentrations of selected antimicrobial agents for Moraxella bovoculi associated with infectious bovine keratoconjunctivitis.
    Angelos JA; Ball LM; Byrne BA
    J Vet Diagn Invest; 2011 May; 23(3):552-5. PubMed ID: 21908289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant Moraxella bovoculi cytotoxin-ISCOM matrix adjuvanted vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Lane VM; Ball LM; Hess JF
    Vet Res Commun; 2010 Mar; 34(3):229-39. PubMed ID: 20217228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled field trial to assess the efficacy of an intranasal
    Angelos JA; Agulto RL; Mandzyuk B; Chigerwe M
    Vaccine X; 2023 Dec; 15():100378. PubMed ID: 37693844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining and Diagnosing Infectious Bovine Keratoconjunctivitis.
    Kneipp M
    Vet Clin North Am Food Anim Pract; 2021 Jul; 37(2):237-252. PubMed ID: 34049656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infectious bovine keratoconjunctivitis: a review of cases in clinical practice.
    Alexander D
    Vet Clin North Am Food Anim Pract; 2010 Nov; 26(3):487-503. PubMed ID: 21056797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early detection of infectious bovine keratoconjunctivitis with artificial intelligence.
    Gupta S; Kuehn LA; Clawson ML
    Vet Res; 2023 Dec; 54(1):122. PubMed ID: 38102629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations to the bovine bacterial ocular surface microbiome in the context of infectious bovine keratoconjunctivitis.
    Gafen HB; Liu CC; Ineck NE; Scully CM; Mironovich MA; Taylor CM; Luo M; Leis ML; Scott EM; Carter RT; Hernke DM; Paul NC; Lewin AC
    Anim Microbiome; 2023 Nov; 5(1):60. PubMed ID: 37996960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious bovine keratoconjunctivitis: effects of vaccination on Moraxella bovis carrier state in cattle.
    Pugh GW; McDonald TJ; Kopecky KE
    Am J Vet Res; 1980 Feb; 41(2):264-6. PubMed ID: 7369598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review of Global Prevalence and Economic Impacts of Infectious Bovine Keratoconjunctivitis.
    Dennis EJ; Kneipp M
    Vet Clin North Am Food Anim Pract; 2021 Jul; 37(2):355-369. PubMed ID: 34049665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infectious bovine keratoconjunctivitis (IBK) in cows, clinical and lab review at four farms].
    Holzhauer M; Visser IJ; van Maanen K
    Tijdschr Diergeneeskd; 2004 Aug; 129(16):526-9. PubMed ID: 15347189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of biofilm-forming capacity of Moraxella bovis, the primary causative agent of infectious bovine keratoconjunctivitis.
    Prieto C; Serra DO; Martina P; Jacobs M; Bosch A; Yantorno OM
    Vet Microbiol; 2013 Oct; 166(3-4):504-15. PubMed ID: 23907059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted next-generation sequencing assay to detect 3
    Wilkes RP; Kattoor JJ; Weng HY; Anis E
    J Vet Diagn Invest; 2024 Jan; 36(1):120-123. PubMed ID: 38018659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious bovine keratoconjunctivitis antimicrobial therapy.
    McConnel CS; Shum L; House JK
    Aust Vet J; 2007; 85(1-2):65-9. PubMed ID: 17300463
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Wilkes RP; Anis E; Kattoor JJ
    Int J Syst Evol Microbiol; 2024 Feb; 74(2):. PubMed ID: 38415687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.